FHJVX
Price
$45.40
Change
+$0.53 (+1.18%)
Updated
Sep 26 closing price
Net Assets
913.46M
VEURX
Price
$42.44
Change
+$0.47 (+1.12%)
Updated
Sep 26 closing price
Net Assets
34.18B
Interact to see
Advertisement

FHJVX vs VEURX

Header iconFHJVX vs VEURX Comparison
Open Charts FHJVX vs VEURXBanner chart's image
Fidelity Advisor Europe M
Price$45.40
Change+$0.53 (+1.18%)
VolumeN/A
Net Assets913.46M
Vanguard European Stock Investor
Price$42.44
Change+$0.47 (+1.12%)
VolumeN/A
Net Assets34.18B
FHJVX vs VEURX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FHJVX vs. VEURX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHJVX is a Buy and VEURX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 34.2B vs. FHJVX (913M). VEURX pays higher dividends than FHJVX: VEURX (2.77) vs FHJVX (2.09). FHJVX was incepted earlier than VEURX: FHJVX (12 years) vs VEURX (35 years). FHJVX (1.17) is less costly to investors than VEURX (0.24). FHJVX is a more actively managed with annual turnover of: 31.00 vs. VEURX (3.00). FHJVX (0) and VEURX (0) have matching initial minimum investment requirements. FHJVX annual gain was more profitable for investors over the last year : 17.12 vs. VEURX (10.43). VEURX return over 5 years is better than : 54.69 vs. FHJVX (30.68).
FHJVXVEURXFHJVX / VEURX
Total Expense Ratio1.170.24488%
Annual Report Gross Expense Ratio1.170.24488%
Fund Existence12 years35 years-
Gain YTD28.97424.460118%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets913M34.2B3%
Annual Yield % from dividends2.092.7775%
Returns for 1 year17.1210.43164%
Returns for 3 years81.2274.41109%
Returns for 5 years30.6854.6956%
Returns for 10 years39.1469.0757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADAP0.150.02
+18.03%
Adaptimmune Therapeutics plc
REAL10.380.29
+2.87%
RealReal (The)
WILC19.140.32
+1.70%
G Willi-Food International Ltd
BMY44.120.71
+1.64%
Bristol-Myers Squibb Co
FOUR79.09-0.69
-0.86%
Shift4 Payments